EUCTR2012-004599-21-FI进行中(未招募)不适用
PHARMACOKINETICS OF ENOXAPARIN IN INTENSIVE CARE PATIENTS
TAYS/teho-osasto0 个研究点开始时间: 2012年12月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Ikä: 18-70v, BMI: 18-30m2, tehohoidon oletettu kesto vähintään 72h, tarve vasopressorille (noradrenaliini)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •Muu indikaatio antikoagulaatiolle kuin laskimotukosehkäisy, edelävän kolmen kuukauden aikana neurokirurginen operaatio tai kallonsisäinen vuoto, DIC, yliherkkyys hepariinille tai pienimolekylaariselle hepariinille, edeltävän 24 tunnin aikana saanut hepariinia tai pienimolekylaarista hepariinia, hoitamaton massiivivuoto, trombosytopenia (trom < 50 E9), p-TT 40%, tiedossa oleva maksasairaus, GFR < 50 ml/MIN/1.73 m2, tiedossa oleva HIV, HBC ai HCV, raskaus
研究者
相似试验
已完成
不适用
Effective prevention of blood clots in critically ill patients - part 2Circulatory SystemVenous thromboembolismISRCTN91570009Odense University Hospital (Denmark)80
已完成
不适用
Effective prevention of blood clots in critically ill patientsVenous thromboembolismCirculatory SystemOther venous embolism and thrombosisISRCTN03037804Odense University Hospital (Denmark)80
招募中
不适用
Safety of enoxaparin in patients undergoing curative hepato-biliary-pancreatic cancer surgerySafety of enoxaparin in patients undergoing curative hepato-biliary-pancreatic cancer surgeryJPRN-UMIN000007761Graduate School of Medicine, Osaka University Department of Gastrointestinal Surgery150
已完成
2 期
Enoxaparin in COVID-19 Moderate to Severe Hospitalized PatientsCOVID-19NCT04427098IRCCS Azienda Ospedaliero-Universitaria di Bologna301
已完成
4 期
Enoxaparin Dosing in ObesityObesityNCT01798550Emory University62
